Capillary Blood Accuracy
NCT: NCT06544070 · WITHDRAWN
NCT IDNCT06544070
StatusWITHDRAWN
Start Date2024-11-04
Completion2025-11-03
SponsorEntia Ltd (INDUSTRY)
First posted
Last updated
Brief Summary
Entia is a health technology company that has developed a blood testing device called Entia Liberty, which analyses blood collected by a finger prick. Entia is sponsoring this research study to compare the results from Entia Liberty finger prick tests to results from the gold-standard laboratory analyser that tests blood from the arm, port, or PICC line.
Frequently Asked Questions
What is Capillary Blood Accuracy?
Capillary Blood Accuracy is a clinical trial registered under NCT06544070. Current status: WITHDRAWN.
What is the status of NCT06544070?
The current status of NCT06544070 (Capillary Blood Accuracy) is: WITHDRAWN.
When did Capillary Blood Accuracy start?
Capillary Blood Accuracy started on 2024-11-04.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.